For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260519:nRSS7176Ea&default-theme=true
RNS Number : 7176E Fevertree Drinks PLC 19 May 2026
19(th) May 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 11(th) May
to 15(th) May 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
11 May 2026 XLON 801.6729 17,992 791.5000 809.5000
11 May 2026 AIMX 805.5000 18,000 805.5000 805.5000
12 May 2026 XLON 780.6957 29,218 770.0000 800.0000
12 May 2026 AIMX 790.6598 14,368 775.0000 797.5000
13 May 2026 XLON 790.0868 23,559 785.5000 796.5000
13 May 2026 AIMX 793.5000 20,000 793.5000 793.5000
14 May 2026 XLON 797.0241 29,385 790.5000 802.5000
14 May 2026 AIMX 794.0000 15,000 794.0000 794.0000
15 May 2026 XLON 778.2958 28,969 764.0000 787.0000
15 May 2026 AIMX 777.0000 15,000 777.0000 777.0000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/7176E_1-2026-5-18.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7176E_1-2026-5-18.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSVVLBFQELLBBV
Copyright 2019 Regulatory News Service, all rights reserved